BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 16232196)

  • 1. Clinical significance of serum NM23-H1 protein in neuroblastoma.
    Okabe-Kado J; Kasukabe T; Honma Y; Hanada R; Nakagawara A; Kaneko Y
    Cancer Sci; 2005 Oct; 96(10):653-60. PubMed ID: 16232196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of a new differentiation pathway in neuroblastoma by copy number defects of N-myc, Cdc42, and nm23 genes.
    Valentijn LJ; Koppen A; van Asperen R; Root HA; Haneveld F; Versteeg R
    Cancer Res; 2005 Apr; 65(8):3136-45. PubMed ID: 15833843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High levels of p19/nm23 protein in neuroblastoma are associated with advanced stage disease and with N-myc gene amplification.
    Hailat N; Keim DR; Melhem RF; Zhu XX; Eckerskorn C; Brodeur GM; Reynolds CP; Seeger RC; Lottspeich F; Strahler JR
    J Clin Invest; 1991 Jul; 88(1):341-5. PubMed ID: 2056128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic implications of the differentiation inhibitory factor nm23-H1 protein in the plasma of aggressive non-Hodgkin's lymphoma.
    Niitsu N; Okabe-Kado J; Kasukabe T; Yamamoto-Yamaguchi Y; Umeda M; Honma Y
    Blood; 1999 Nov; 94(10):3541-50. PubMed ID: 10552965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum nm23-H1 protein as a prognostic factor in hematological malignancies.
    Okabe-Kado J
    Leuk Lymphoma; 2002 Apr; 43(4):859-67. PubMed ID: 12153176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The N-myc and c-myc downstream pathways include the chromosome 17q genes nm23-H1 and nm23-H2.
    Godfried MB; Veenstra M; v Sluis P; Boon K; v Asperen R; Hermus MC; v Schaik BD; Voûte TP; Schwab M; Versteeg R; Caron HN
    Oncogene; 2002 Mar; 21(13):2097-101. PubMed ID: 11960382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma levels of the differentiation inhibitory factor nm23-H1 protein and their clinical implications in acute myelogenous leukemia.
    Niitsu N; Okabe-Kado J; Nakayama M; Wakimoto N; Sakashita A; Maseki N; Motoyoshi K; Umeda M; Honma Y
    Blood; 2000 Aug; 96(3):1080-6. PubMed ID: 10910925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for nm23 RNA overexpression, DNA amplification and mutation in aggressive childhood neuroblastomas.
    Leone A; Seeger RC; Hong CM; Hu YY; Arboleda MJ; Brodeur GM; Stram D; Slamon DJ; Steeg PS
    Oncogene; 1993 Apr; 8(4):855-65. PubMed ID: 8384356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physiological and pathological relevance of extracellular NM23/NDP kinases.
    Okabe-Kado J; Kasukabe T
    J Bioenerg Biomembr; 2003 Feb; 35(1):89-93. PubMed ID: 12848346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biological diagnosis for neuroblastoma using the combination of highly sensitive analysis of prognostic factors.
    Tajiri T; Tanaka S; Higashi M; Kinoshita Y; Takahashi Y; Tatsuta K; Suita S
    J Pediatr Surg; 2006 Mar; 41(3):560-6. PubMed ID: 16516635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MYCN RNA levels determined by quantitative in situ hybridization is better than MYCN gene dosages in predicting the prognosis of neuroblastoma patients.
    Chang HH; Tseng YF; Lu MY; Yang YL; Chou SW; Lin DT; Lin KH; Jou ST; Hsu WM; Jeng YM
    Mod Pathol; 2020 Apr; 33(4):531-540. PubMed ID: 31695155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical significance of intracytoplasmic nm23-H1 expression in diffuse large B-cell lymphoma.
    Niitsu N; Nakamine H; Okamoto M; Akamatsu H; Higashihara M; Honma Y; Okabe-Kado J; Hirano M
    Clin Cancer Res; 2004 Apr; 10(7):2482-90. PubMed ID: 15073128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enlarged and prominent nucleoli may be indicative of MYCN amplification: a study of neuroblastoma (Schwannian stroma-poor), undifferentiated/poorly differentiated subtype with high mitosis-karyorrhexis index.
    Kobayashi C; Monforte-Munoz HL; Gerbing RB; Stram DO; Matthay KK; Lukens JN; Seeger RC; Shimada H
    Cancer; 2005 Jan; 103(1):174-80. PubMed ID: 15549714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical significance of a highly sensitive analysis for gene dosage and the expression level of MYCN in neuroblastoma.
    Tanaka S; Tajiri T; Noguchi S; Shono K; Ihara K; Hara T; Suita S
    J Pediatr Surg; 2004 Jan; 39(1):63-8. PubMed ID: 14694373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical significance of nm23-H1 proteins expressed on cell surface in non-Hodgkin's lymphoma.
    Niitsu N; Honma Y; Iijima K; Takagi T; Higashihara M; Sawada U; Okabe-Kado J
    Leukemia; 2003 Jan; 17(1):196-202. PubMed ID: 12529678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Co-downregulation of PTEN, KAI-1, and nm23-H1 tumor/metastasis suppressor proteins in non-small cell lung cancer.
    Goncharuk VN; del-Rosario A; Kren L; Anwar S; Sheehan CE; Carlson JA; Ross JS
    Ann Diagn Pathol; 2004 Feb; 8(1):6-16. PubMed ID: 15129904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Read-through transcript from NM23-H1 into the neighboring NM23-H2 gene encodes a novel protein, NM23-LV.
    Valentijn LJ; Koster J; Versteeg R
    Genomics; 2006 Apr; 87(4):483-9. PubMed ID: 16442775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of the relationship between MYCN gene and serum NSE and urinary VMA levels and neuroblastoma pathological features and prognosis.
    Zhang H; He X; Miao Q; Li L; Song J; Jiang X
    Cell Mol Biol (Noisy-le-grand); 2024 Apr; 70(4):134-139. PubMed ID: 38678619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroblastoma specific effects of DR-nm23 and its mutant forms on differentiation and apoptosis.
    Negroni A; Venturelli D; Tanno B; Amendola R; Ransac S; Cesi V; Calabretta B; Raschellà G
    Cell Death Differ; 2000 Sep; 7(9):843-50. PubMed ID: 11042679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated plasma level of differentiation inhibitory factor nm23-H1 protein correlates with risk factors for myelodysplastic syndrome.
    Ito Y; Okabe-Kado J; Honma Y; Iwase O; Shimamoto T; Ohyashiki JH; Ohyashiki K
    Leukemia; 2002 Feb; 16(2):165-9. PubMed ID: 11840281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.